Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant ®) stored in the original vials over 28 days
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant ®) stored in the original vials over 28 days ; volume:9 ; number:1 ; year:2024 ; extent:06
Pharmaceutical technology in hospital pharmacy ; 9, Heft 1 (2024) (gesamt 06)
- Urheber
-
Knoll, Laura
Thiesen, Judith
Krämer, Irene
- DOI
-
10.1515/pthp-2024-0001
- URN
-
urn:nbn:de:101:1-2405231543230.689953297078
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Knoll, Laura
- Thiesen, Judith
- Krämer, Irene
Ähnliche Objekte (12)
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Vial
Vial
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar
Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Vial, Gottlieb
Vial, Alexander
Vial, A.
Vial, A.
Vial, Irmgard
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Vial
Vial
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar
Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Vial, Gottlieb
Vial, Alexander
Vial, A.
Vial, A.
Vial, Irmgard
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
Vial
Vial
Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar
Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
Vial, Gottlieb
Vial, Alexander
Vial, A.
Vial, A.